Transition Therapeutics Profile

1.93
CAD 0.00  0.00%
1.92Last Month High 2.17 
1.93Trading Day  High 1.93 

Transition Therapeutics Risk Profiles

Key Fundamentals

Transition Therapeutics Against Markets

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications primarily in Canada. more
NameTransition Therapeutics Inc
Macroaxis Advice
InstrumentCanada Stock Stocks Directory
Business AddressToronto, ON MG L
ExchangeToronto Stock Exchange
BenchmarkDOW
Websitewww.transitiontherapeutics.com
Contact Number416 260 7770
CurrencyCAD - Canadian Dollar

Directors

Transition Therapeutics Corporate Directors
Christopher Henley Independent Director
Gary Pace Independent Director, Ph.D
Paul Baehr Independent Director

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas